Halberd

Halberd EV/Revenue

The EV/Revenue (Enterprise Value to Revenue) of Halberd (HALB) as of Oct 28, 2026 is 971.09. In the previous year, EV/Revenue (Enterprise Value to Revenue) was 355.41 — a change of 173.23% (higher).

EV/Revenue

971.09

YoY

173.23%

Last updated:

EV/Revenue (Enterprise Value to Revenue) of Halberd is 2024 971.09 . EV/Revenue (Enterprise Value to Revenue) of Halberd was 2023 355.41 . It decreases by 173.23% higher compared to the previous year.

The Halberd EV/Revenue history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EV/Revenue
Date
EV/Revenue
Jan 1, 2014
3.62 USD
Jan 1, 2015
9.39 USD
Jan 1, 2016
9.17 USD
Jan 1, 2017
8.50 USD
Jan 1, 2021
178.52 USD
Jan 1, 2022
120.43 USD
Jan 1, 2023
355.41 USD
Jan 1, 2024
971.09 USD
The Halberd EV/Revenue history
YEAREV/RevenueYoY
971.09+173.23%
355.41+195.11%
120.43-32.54%
178.52+1,999.52%
8.50-7.32%
9.17-2.25%
9.39+159.43%
3.62—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Halberd Stock analysis

What does Halberd do? The Halberd Corp is an American company founded in 1987 and based in New York. It is a high-tech company focused on the development of medical technologies. Since its inception, the company has developed numerous innovative products and technologies that are used worldwide. A significant portion of Halberd Corp's business model focuses on providing medical products and solutions for various diseases. The main divisions of the company are biotechnology and pharmaceuticals, medical respiratory protection, medical technology, and the development of antibodies and diagnostics. Some of the most well-known products of Halberd Corp are the Medical Respiratory Masks, which were of great importance during the COVID-19 pandemic. These masks were developed and distributed worldwide by the company with innovative technology and the highest quality standards. The company has also developed various medical devices such as infusion pumps, blood pressure monitors, and various diagnostic devices that have been used by hospitals and care facilities. Another important business area of Halberd Corp is biotechnology and pharmaceuticals. In this field, the company specializes in developing new drugs and therapies for various diseases. The company has developed a range of proprietary medications that are used in the treatment of various diseases. Halberd Corp is also known for its development of antibodies and diagnostics and offers corresponding test kits. In recent years, Halberd Corp has formed numerous partnerships with other companies and institutions to bring its innovations to the market and market them. The company is also known for its successful joint ventures with other companies in the healthcare sector. Overall, Halberd Corp is an innovative company focused on medical technologies. With its presence in various areas of the healthcare industry, the company is able to develop new products and solutions that have the potential to improve and save lives. Halberd is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Halberd stock

EV/Revenue (Enterprise Value to Revenue) of Halberd is 971.09 in 2024.

EV/Revenue (Enterprise Value to Revenue) of Halberd changed from 355.41 to 971.09, representing a 173.23% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of EV/Revenue (Enterprise Value to Revenue) Halberd since 2006 – with annual values, charts, and detailed analysis.

The EV/Revenue ratio compares a company's enterprise value to its total revenue. It is particularly useful for valuing high-growth companies that may not yet be profitable.

To evaluate EV/Revenue (Enterprise Value to Revenue)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for EV/Revenue (Enterprise Value to Revenue).

A 'good' varies by industry and company stage. On Eulerpool, you can compare EV/Revenue (Enterprise Value to Revenue)'s Halberd with sector peers and the industry average to assess whether it is attractive.

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Valuation — Halberd

All Key Metrics — Halberd